Your browser doesn't support javascript.
loading
Probiotics for children with uncomplicated severe acute malnutrition (PruSAM study): A randomized controlled trial in the Democratic Republic of Congo.
Kambale, Richard Mbusa; Ntagazibwa, Joseph Ntagerwa; Kasengi, Joe Bwija; Zigashane, Adrien Burume; Francisca, Isia Nancy; Mashukano, Benjamin Ntaligeza; Amani Ngaboyeka, Gaylord; Bahizire, Esto; Zech, Francis; Bindels, Laure B; Van der Linden, Dimitri.
Afiliação
  • Kambale RM; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democ
  • Ntagazibwa JN; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of Congo.
  • Kasengi JB; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of Congo.
  • Zigashane AB; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of Congo.
  • Francisca IN; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of Congo.
  • Mashukano BN; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; General Pediatrics, Pediatric Department, Hôpital Provincial Général de Référence de Bukavu, Bukavu, Democratic Republic of Congo.
  • Amani Ngaboyeka G; Ecole Régionale de Santé Publique, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo.
  • Bahizire E; Faculty of Medicine, Université catholique de Bukavu, Bukavu, Democratic Republic of Congo; Center for Tropical Diseases and Global Health, Université catholique de Bukavu, Bukavu, Democratic Republic of the Congo; Center for Research in Natural Sciences of Lwiro, Bukavu, Democratic Republic of the
  • Zech F; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
  • Bindels LB; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
  • Van der Linden D; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium; Pediatric Infectious Diseases, Specialized Pediatrics Service, Pediatric Department, Cliniques universitaires Saint Luc, Brussels, Belgium.
Am J Clin Nutr ; 117(5): 976-984, 2023 05.
Article em En | MEDLINE | ID: mdl-37137616
ABSTRACT

BACKGROUND:

Severe acute malnutrition (SAM) contributes to nearly 1 million deaths annually worldwide, with diarrhea and pneumonia being the common morbidity associated with mortality.

OBJECTIVES:

To assess the effect of probiotics on diarrhea, pneumonia, and nutritional recovery in children with uncomplicated SAM.

METHODS:

A randomized, double-blind, placebo-controlled study was conducted involving 400 children with uncomplicated SAM randomly assigned to ready-to-use therapeutic food (RUTF) either with (n = 200) or without (n = 200) probiotics. Patients received 1 mL daily dose of a blend of Lacticasebacillus rhamnosus GG and Limosilactobacillus reuteri DSM 17938 (dosage, 2 billion colony-forming units; 5050) or placebo during 1 mo. They were simultaneously fed with the RUTF for 6 to 12 wk, depending on patients' recovery rates. The primary outcome was the duration of diarrhea. Secondary outcomes included diarrheal and pneumonic incidence, nutritional recovery, and transfer to inpatient care rate.

RESULTS:

For children with diarrhea, the number of days of disease was lower in the probiotic group (4.11; 95% CI 3.37, 4.51) than that in the placebo group (6.68; 95% CI 6.26, 7.13; P < 0.001). For children aged 16 mo or older, the risk of diarrhea was lower in the probiotic group (75.6%; 95% CI 66.2, 82.9) than that in the placebo group (95.0%; 95% CI 88.2, 97.9; P < 0.001), but no significant difference of the risk for the youngest. In the probiotic group, nutritional recovery happened earlier at the 6th wk, 40.6% of the infants were waiting for nutritional recovery, contrasting with 68.7% of infants in the placebo group; but the nutritional recovery rate at the 12th wk was similar between the groups. Probiotics had no effect on pneumonic incidence and transfer to inpatient care.

CONCLUSIONS:

This trial supports using probiotics for the treatment of children with uncomplicated SAM. Its effect on diarrhea could positively affect nutritional programs in resource-limited settings. This trial was registered https//pactr.samrc.ac.za as PACTR202108842939734.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Probióticos / Desnutrição Aguda Grave Tipo de estudo: Clinical_trials / Etiology_studies Limite: Child / Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Probióticos / Desnutrição Aguda Grave Tipo de estudo: Clinical_trials / Etiology_studies Limite: Child / Humans / Infant País/Região como assunto: Africa Idioma: En Revista: Am J Clin Nutr Ano de publicação: 2023 Tipo de documento: Article